These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2141682)

  • 21. C3, C4, and the terminal complement complex differ from C1q by binding predominantly to the antigenic part of solid phase immune complexes.
    Garred P; Michaelsen TE; Aase A; Mollnes TE
    J Immunol; 1990 Jan; 144(1):198-203. PubMed ID: 2295791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating immune complex levels measured by new ELISA kits utilizing monoclonal anti-C1q and anti-C3d antibodies correlate with clinical activities of SLE but not with those of RA.
    Yoshinoya S; Mizoguchi Y; Aotsuka S; Yokohari R; Nishioka K; Miyamoto T
    J Clin Lab Immunol; 1992; 38(4):161-73. PubMed ID: 11270517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determination of circulating immune complexes, C3 and C4 complement components and anti-DNA antibody in different classes of lupus nephritis.
    Klein MH; Thorner PS; Yoon SJ; Poucell S; Baumal R
    Int J Pediatr Nephrol; 1984 Jun; 5(2):75-82. PubMed ID: 6333404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Soluble immune complexes in sera of patients with nephritis.
    Rossen RD; Reisberg MA; Singer DB; Schloeder FX; Suki WN; Hill LL; Eknoyan G
    Kidney Int; 1976 Sep; 10(3):256-63. PubMed ID: 135115
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Immune complex and complement levels in spontaneous abortions and normal pregnancy].
    Saitoh S; Nakanishi A; Ichijo M
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 Nov; 35(11):1981-90. PubMed ID: 6607297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Circulating immune complexes in children, particularly in those with damage to the small intestine mucosa].
    Kaczmarski M
    Pediatr Pol; 1982 Nov; 57(11):891-6. PubMed ID: 6221228
    [No Abstract]   [Full Text] [Related]  

  • 27. Immune complexes: characteristics, clinical correlations, and interpretive approaches in the clinical laboratory.
    Ritzmann SE; Daniels JC
    Clin Chem; 1982 Jun; 28(6):1259-71. PubMed ID: 6210468
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Study of circulating immune complexes during the evolution of visceral Mediterranean leishmaniasis.
    Makni S; Ayed K; Ben Said M; Ben Rachid MS
    Ann Trop Med Parasitol; 1989 Aug; 83(4):349-55. PubMed ID: 2532497
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determination of complement activating circulating immune complexes and an example for antigen specific immune complex assays.
    Krapf F; Fuchs C; Herrmann M; Hoferichter S; Kalden JR
    J Clin Lab Immunol; 1986 Dec; 21(4):183-7. PubMed ID: 3550093
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies on the haemolytic activity of circulating C1q-C3/C4 complexes.
    Wouters D; Brouwer MC; Daha MR; Hack CE
    Mol Immunol; 2008 Apr; 45(7):1893-9. PubMed ID: 18054386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measles and acute glomerulonephritis.
    Lin CY; Hsu HC
    Pediatrics; 1983 Mar; 71(3):398-401. PubMed ID: 6219335
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Complement components, whole complement activity, and circulating immune complexes in neoplastic diseases].
    Takada K; Morishita M; Sugiura T; Suzuki M; Torii Y; Ichimura K; Hashigami H; Toshikawa K; Ina Y; Yamamoto M; Oyama A; Urata A
    Gan No Rinsho; 1983 Apr; 29(4):A-19, 293-6. PubMed ID: 6602233
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel ELISA for the evaluation of the classical pathway of complement.
    Zwirner J; Wittig A; Kremmer E; Götze O
    J Immunol Methods; 1998 Feb; 211(1-2):183-90. PubMed ID: 9617842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complement and sepsis.
    Gutiérrez-Fernández J; Maroto MC; Piédrola G; Zamora E
    Allergol Immunopathol (Madr); 1987; 15(3):145-9. PubMed ID: 3661354
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complement-mediated solubilization of immune complexes in systemic lupus erythematosus.
    Sakurai T; Fujita T; Kono I; Kabashima T; Yamane K; Tamura N; Kashiwagi H
    Clin Exp Immunol; 1982 Apr; 48(1):37-42. PubMed ID: 6979449
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Determination of immunocomplexes. IV. Detection of immune complexes using the C3 and C4 component of complement].
    Votruba T; Rákosník P
    Cesk Epidemiol Mikrobiol Imunol; 1988 Jul; 37(4):199-206. PubMed ID: 2981003
    [No Abstract]   [Full Text] [Related]  

  • 37. Studies of urticaria and acute serum sickness with the C1q precipitin test.
    Lieberman P; Rice MC; Mallette JE
    Arch Intern Med; 1977 Apr; 137(4):440-2. PubMed ID: 139855
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Functional analysis of immune complex-rich serum fractions in autoimmune diseases by in vitro C3 activation of fresh blood].
    Böhm U; Merétey K; Falus A; Bozsóky S
    Z Rheumatol; 1981; 40(3):126-30. PubMed ID: 6456623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating immune complexes in healthy persons.
    Jans H; Dybkjaer E; Halberg P
    Scand J Rheumatol; 1982; 11(4):194-8. PubMed ID: 7178855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complement activation and C1q binding activity in haemodialysis.
    Dodd NJ; Vergani D; Turney JH; Parsons V; Weston MJ
    Proc Eur Dial Transplant Assoc; 1981; 18():300-4. PubMed ID: 6977138
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.